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ABSTRACT   
 
The linear combinations of dichotomous variables over the field 𝔽2, which are called symptoms, form the 
projective space from which it is possible select the more informative subspaces for reducing the 
dimensionality of binary data. In this article, the symptom space expands to the super-symptom space. The 
super-symptom means a linear combination of various multiplications of 𝑘 dichotomous variables over a 
field of characteristic 2 without repeating. In algebra, such functions are called Zhegalkin polynomials or 
algebraic normal forms. It is known that each logical function can be represented in the form of a 
Zhegalkin polynomial in a unique way, therefore using them to iterate one can find a logical function to 
best describe a risk group. The search algorithm of a more informative super-symptom for classification is 
based on the superposition of impulse sequences with different types of operations: first multiplication and 
then addition over the 𝔽2 field. Also the super-symptom analysis is a convenient method for a study of the 
correlation between two sets of categorical variables. This method was applied to identify the most severe 
forms of the disease by combining hormonal, immunological and genetic tests in patients with breast 
cancer (data from Cancer Oncology Hospital in Medicine City in Baghdad) and to identify genetic risk 
factors by patients with alcohol dependence syndrome, receiving alcohol dependence therapy 
(St.Petersburg V.M. Bekhterev Psychoneurological Research Institute).  
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1. Introduction 
The statistical task of comparing a single dependent variable with a complex of several independent 
dichotomous variables remains actual, especially, when the influence of various factors on the dependent 
variable is being studied separately, and all interrelations are insignificant. Separate factors are sometimes not 
enough to describe the risk group. If many factors are considered then there is a problem of the dimension 
reduction which means search for a few functions of factors with the least information loss. Models of such 
functions may be different. 
In this article, we can use the symptom-syndrome models [1] in which the predicate is expressed in terms of 
independent factors as linear combinations over field 𝔽2, which form the finite projective space [2]. 
If we construct a finite projective space not for 𝑘 dichotomous variables, but for their 2𝑘 − 1 various non-
degenerate multiplications without repetition, then we receive Zhegalkin polynomials which describe all sorts 
of logical functions – all possible combinations of logic operations: addition, negation, multiplication of these 
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𝑘 variables. The main problem lies in the complexity of calculations. Modern computing capabilities make it 
easy to operate with up to three-four of dependent factors. But if you first find the three or four most 
significant variables, then they will be enough to determine the risk group using one variable, which is 
expressed through a logical combination of these factors. 
To check the independence of a pair of categorical variables, one can use the uncertainty coefficient or the 𝑝-
value of Fisher exact test [3], application example in symptom analysis [4]. In the case of the metric 
dependent variable, the homogeneity tests: 𝑡-test, the Kruskal Wallis test or ANOVA are used [5]. The Gehan 
Wilcoxon test [6] is used in survival symptom analysis [7]. 
 
2. Material and methods 
2.1. Symptom and super-symptom 
Consider random vector 𝑋 = (𝑋1, … , 𝑋𝑚)
T with components taking values 0 and 1. Usually 0 and 1 mean 
lack and presence of factors respectively. The new variable 𝑋𝑖𝑗 = 𝑋𝑖 + 𝑋𝑗(mod2) 
1 also takes only values 0 
and 1 and means presence of any one in the absence of another factor. This latent variable is called the 
symptom. For example, if 𝑋𝑖 and 𝑋𝑗 direct to the big height and the big weight respectively then 𝑋𝑖𝑗 = 1 
means inadequacy of height to weight: tall and thin or short and fat. Contrariwise 𝑋𝑖𝑗 = 0 means that weight 
is adequate for height: short and lightweight or tall and heavyweight. We can consider the such sum of 𝑘 
variables, the meaning of which at 𝑘 > 2 is more complicated and will be discussed further.  
Definition 1 Let be τ = (t1, … , tk) ⊆ (1,2, … , m). Then Xτ = ∑
k
i=1 Xti(mod2) is called the symptom Xτ of 
the rank k.  
 We note again, since all operations are performed over the field 𝔽2 all symptoms take only values of 
0 or 1. Let 𝜏 = (1,2,3) and 𝑋123 = 𝑋1 + 𝑋2 + 𝑋3(mod2) takes a value of 0 when all factors are equal to 0 or 
the value of 0 occurs only once. The symptom 𝑋123 = 1 when all factors are equal to 1 or the value of 1 
occurs only once. The variable 𝑋12 means that if 𝑋1 = 0 then 𝑋2 = 1 or if 𝑋1 = 1 then 𝑋2 = 0. The elements 
of vector 𝑋 = (𝑋1, … , 𝑋𝑚)
T are trivial symptoms of rank 1. We define symptom of rank zero degenerate, it 
takes a value of 0 with a probability of 1. 
 
Definition 2  Let τ = (t1, … , tk) ⊆ (1,2, … , m) be one of 2
m − 1 subsets with the exception of the empty set 
∅, where k ≤ m. We denote the result of multiplying several dichotomous variables Xt1 , … , Xtk by X
τ = Xt1 ⋅
… ⋅ Xtk. For different τ1, … , τL polynomials over the field 𝔽2 of the form ∑
L
i=1 X
τi(mod2) are called super-
symptoms.  
In particular, the super-symptom 𝑠1 = 𝑋1 + 𝑋2 + 𝑋1𝑋2(mod2) means presence 𝑋1 or 𝑋2 or both together 
when 𝑠1 = 1, which corresponds to the logical sum. When 𝑠1 = 0 then 𝑋1 = 0 and 𝑋2 = 0 at the same time. 
The super-symptom 𝑠2 = 𝑋1𝑋2 + 𝑋1𝑋3 + 𝑋2𝑋3(mod2) means presence not less two out three factors 
𝑋1, 𝑋2, 𝑋3 at 𝑠2 = 1. When 𝑠2 = 0 then all 𝑋1, 𝑋2, 𝑋3 are equal 0 or 𝑋𝑖 = 1 separately, i.e the vector 𝑋 =
(𝑋1, 𝑋2, 𝑋3) takes values (0,0,0), (1,0,0), (0,1,0), (0,0,1). 
Remark that the super-symptom ?̅? = 𝑠 + 1(mod2) differs from the super-symptom 𝑠 only in order of 
graduations. For example 𝑠 = 1 and 𝑠 = 0 mean the big and small height respectively. On the contrary ?̅? = 1 
and ?̅? = 0 mean the small and big height respectively. Thus we can treat 𝑠 and ?̅? as one and the same super-
symptom when it meets in isolation without other super-symptoms. So we consider as super-symptoms all 
polynomials over the field 𝔽2 with zero free member without loss of generality. 
In [5], there is the definition of projective geometry 𝑃𝐺(𝑛, 𝑞) that the vectors 𝑋0, … , 𝑋𝑛 form over a finite 
field 𝔽𝑞. Similarly introduce the following definition. 
Definition 3 Let be there are linearly independent symptoms X1, … , Xk, coefficients γj ∈ 𝔽2, j = 1, … , k, γj are 
not zero at the same time. Then a collection of 2k − 1 symptoms in the form γ1X1 + ⋯ + γkXk(mod2) is 
called the syndrome Sk.  
 
 
1  The expression 𝑎(mod2) means the remainder of a division of the number 𝑎 by 2. This corresponds to that all operations are performed over the field 
𝔽2.  
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The single symptom 𝑋𝜏 can be considered as a syndrome 𝑆1 which is analogous to the point 𝑃𝐺(0,2). 
Symptoms 𝑋𝜏, 𝑋𝜇 and 𝑋𝜏𝜇 = 𝑋𝜏 + 𝑋𝜇(mod2) form the syndrome 𝑆2 which is analogous to the projective line 
𝑃𝐺(1,2). Just as a projective line can only be defined by two points, the syndrome 𝑆2 can be built on any pair 
of variables because 𝑋𝜏𝜇 = 𝑋𝜏 + 𝑋𝜇(mod2), 𝑋𝜇 = 𝑋𝜏𝜇 + 𝑋𝜏(mod2), 𝑋𝜏 = 𝑋𝜏𝜇 + 𝑋𝜇(mod2). The syndrome 
𝑆3 or projective plane 𝑃𝐺(2,2) can be built on any three of linear independent variables and so on. 
Similar to inductive construction of projective geometries the introduction of a new point, not belonging to 
finite geometry, and through the construction of all lines containing this point, it is possible to determine the 
syndrome 𝑘 − 1 - th order on the base of linearly independent symptoms 𝑋𝑡1 … , 𝑋𝑡𝑘 recurrently:  
  𝑆1 = 𝑆1(𝑋𝑡1) = 𝑋𝑡1  , 
 𝑆2 = 𝑆2(𝑋𝑡1 , 𝑋𝑡2) = (𝑋𝑡1 , 𝑋𝑡2 , 𝑋𝑡1 + 𝑋𝑡2(mod2)), 
 ⋮ (1) 
 𝑆𝑖 = 𝑆𝑖(𝑋𝑡1 , … , 𝑋𝑡𝑖) = ( 𝑆𝑖−1, 𝑋𝑡𝑖 , 𝑆𝑖−1 + 𝑋𝑡𝑖(mod2)), 
   𝑤ℎ𝑒𝑟𝑒  𝑋𝑡𝑖 ∉ 𝑆𝑖−1, 𝑖 > 2 . 
 The symptoms of 𝑆𝑘(𝑋1, … , 𝑋𝑘) form an impulse sequence with 2
𝑘 − 1 = 𝐾 elements. For example, 
𝑆3(𝑋1, 𝑋2, 𝑋3) looks like (𝑋1, 𝑋2, 𝑋12, 𝑋3, 𝑋12, 𝑋13, 𝑋123). The elements on the 2
𝑖-nd place are called basic. If 
we take as basic the symptoms 𝑋12, 𝑋13, 𝑋2 then 𝑆3(𝑋12, 𝑋13, 𝑋2) = (𝑋12, 𝑋13, 𝑋23, 𝑋2, 𝑋1, 𝑋123, 𝑋3). Remark 
that syndromes 𝑆3(𝑋1, 𝑋2, 𝑋3) and 𝑆3(𝑋12, 𝑋13, 𝑋2 different only by order of elements. We can generalize an 
impulse sequence (1) when we use any operation on the field 𝔽2, not just addition. We define a special 
impulse sequence from (𝑋𝑡1 , … , 𝑋𝑡𝑘), 𝑋𝑡𝑖 ∈ 𝑆𝑘 with operation (*).  
  𝑀1 = 𝑀1(𝑋𝑡1| ∗) = 𝑋𝑡1  , 
 𝑀2 = 𝑀2(𝑋𝑡1 , 𝑋𝑡2| ∗) = (𝑋𝑡1 , 𝑋𝑡2 , 𝑋𝑡1 ∗ 𝑋𝑡2), 
 ⋮ (2) 
 𝑀𝑖 = 𝑀𝑖(𝑋𝑡1 , … , 𝑋𝑡𝑖| ∗) = ( 𝑀𝑖−1, 𝑋𝑡𝑖 , 𝑀𝑖−1 ∗ 𝑋𝑡𝑖), 
   𝑤ℎ𝑒𝑟𝑒   𝑋𝑡𝑖 ∈ 𝑀𝑖−1 , 𝑖 > 1 . 
 One can see a match 𝑀𝑘(𝑋|+) = 𝑆𝑘(𝑋) for 𝑋 = (𝑋1, … , 𝑋𝑘). In case of multiplication (⊙) over the field 𝔽2 
and 𝑘 = 2 we have 𝑀2(𝑋1, 𝑋2| ⊙) = (𝑋1, 𝑋2, 𝑋1𝑋2) which consists of 𝐾 = 2
2 − 1 = 3 elements. In case 𝑘 =
3, 𝑀3(𝑋1, 𝑋2, 𝑋3| ⊙) = (𝑋1, 𝑋2, 𝑋1𝑋2, 𝑋3, 𝑋1𝑋3, 𝑋2𝑋3, 𝑋1𝑋2𝑋3) consists of 𝐾 = 2
3 − 1 = 7 elements and so 
on. We can use these elements as basic for the syndrome. Thus, we get a simple way to construct a super-
syndrome as 𝑆𝐾(𝑀𝑘(𝑋1, 𝑋2, … , 𝑋𝑘| ⊙)), where 𝐾 = 2
𝑘 − 1, which includes all 2𝐾 − 1 polynomials over the 
field 𝔽2 with free member equal 0. 
For example, the impulse ordered syndrome over the field 𝔽2 at 𝑘 = 2 includes 2
22−1 − 1 = 7 
polynomials:  𝑆3(𝑀1(𝑋1, 𝑋2| ⊙)) = 𝑆3(𝑋1, 𝑋2, 𝑋1𝑋2) = (𝑋1, 𝑋2, 𝑋1 + 𝑋2, 𝑋1𝑋2, 𝑋2 + 𝑋1𝑋2, 𝑋2 + 𝑋1𝑋2, 𝑋1 +
𝑋2 + 𝑋1𝑋2) All these super-symptoms have a simple logical interpretation: the new factor 𝑋1𝑋2 direct to that 
factors 𝑋1 and 𝑋2 are present at the same time, 𝑋2 + 𝑋1𝑋2(mod2) = ?̅?1𝑋2 means that the factor 𝑋2 is present 
and the other 𝑋1 is absent
2, 𝑋1 + 𝑋1𝑋2 = 𝑋1?̅?2 contrariwise. The super-symptom 𝑋1 + 𝑋2 + 𝑋1𝑋2(mod2) =
1 + ?̅?1?̅?2(mod2) corresponds to the logic sum. As mentioned earlier, the symptom 𝑋12 = 𝑋1 + 𝑋2(mod2) 
means the presence of one factor in the absence of another which corresponds to the logic sum of factors 𝑋1?̅?2 
and ?̅?1𝑋2,  
 𝑋1?̅?2 + ?̅?1𝑋2 + ?̅?1𝑋2?̅?2𝑋1(mod2) = 
 = 𝑋1 + 𝑋1𝑋2 + 𝑋2 + 𝑋1𝑋2(mod2) = 𝑋1 + 𝑋2(mod2) = 𝑋12 . 
 
2.2. Selection algorithm 
Let the dichotomous variables 𝑋1, … , 𝑋𝑚 be involved separately in some statistical test. We consider all 
possible combinations 𝑋𝑡1 , 𝑋𝑡2 , 𝑋𝑡3 and then calculate all possible elements 𝑌𝑗 ∈ 𝑆7(𝑀3(𝑋𝑡1 , 𝑋𝑡2 , 𝑋𝑡3)), where 
𝑡1, 𝑡2, 𝑡3 ∈ {1,2, … , 𝑚}, 𝑗 = 1, … , 2
7 − 1. In each case entropy 𝐻𝑗 of the super-symptom 𝑌𝑗 and appropriate 𝑝-
value 𝑝𝑗 are calculated. Factor 𝑌𝑗 is considered significant when 𝑝𝑗 < 0.005 adjusted for multiple 
comparisons and 𝐻𝑗 > 0.05. Thus we choose the most significant super-symptom. 
Each of 127 = 27 − 1 possible super-symptoms constructed from three variables 𝑎, 𝑏, 𝑐 ∈ {𝑋1, … , 𝑋𝑚} can be 
expressed both as a polynomial modulo 2 and as a combination of logical operations. Almost half of the 
 
2 The factor ?̅? = 𝑋 + 1(mod2) is opposite to the factor 𝑋.  
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super-symptoms (63 out of 127) have a fairly simple interpretation. First of all, expressions 𝛼𝑘1𝛽𝑘2𝛾𝑘3 are 
easily interpreted, where  
 𝛼 ∈ {𝑎, ?̅?}, 𝛽 ∈ {𝑏, ?̅?}, 𝛾 ∈ {𝑐, 𝑐̅} . (3) 
 Multiplication of several symptoms means that all of there take a value 1 at the same time. Degrees 𝑘1, 𝑘2, 𝑘3 
take values 0 or 1 and these 23 = 𝐶3
1 + ∑3𝑗=2 𝐶3
𝑗
2𝑗 expressions look like Table 1. 
 
Table 1. Types of expressions 
 
The expression 𝛼𝛽 + 𝛼𝛾 + 𝛽𝛾(mod2) means the presence of two or more factors from 𝛼, 𝛽, 𝛾. There are 
eight variants for such expressions depending on (3). One can see that if we replace all the variables with 
opposite then we get the same polynomial but with the free member equal 1, i.e. ?̅??̅? + ?̅??̅? + ?̅??̅?(mod2) =
𝛼𝛽 + 𝛼𝛾 + 𝛽𝛾 + 1(mod2). But since the super-symptoms are determined with precision about the 
permutation of gradations, we have four polynomials of the form: 𝑎𝑏 + 𝑎𝑐 + 𝑏𝑐, ?̅?𝑏 + ?̅?𝑐 + 𝑏𝑐, 𝑎?̅? + 𝑎𝑐 +
?̅?𝑐, 𝑎𝑏 + 𝑎𝑐̅ + 𝑏𝑐̅(mod2). 
We can construct 24 = 𝐶3
1 ⋅ 23 super-symptoms of the form 𝛼(𝛽 + 𝛾 + 𝛽𝛾), corresponding to the presence of 
factors 𝛼 simultaneously with 𝛽 or 𝛾, where 𝐶3
1 indicates that three kind of variables can be aside and 23 is the 
number of variants depending on (3). 
Finally, we can add 12 = 𝐶3
1 ⋅ 22 expressions of the form 𝛼𝛽 + (𝛼 + 1)𝛾, corresponding to the presence of 
factor 𝛼 together with 𝛽 or the opposite ?̅? with factor 𝛾. There are four expression instead of eight variants 
depending on (3), because for all 𝛼 ∈ {𝑎, ?̅?} we have 𝛼𝑏 + ?̅?𝑐 = 𝛼?̅? + ?̅?𝑐̅ + 1 and 𝛼?̅? + ?̅?𝑐 = 𝛼𝑏 + ?̅?𝑐̅ + 1. 
Other super-symptoms can also be expressed through logical functions, but in a more complex way. 
Sometimes several super-symptoms have comparable 𝑝-values. In this case, it becomes possible to choose as 
a nominative representative the factor which is more accessible for interpretation. 
3. Calculation and results 
In statistical analysis the data or variable selection is an active research area. Before starting to apply the 
classification method, the variable selection methods could be used to minimize the number of features in the 
research dataset. Therefore, the purpose standing behind variable selection is to select a subset of variables by 
ignoring features with less important information. This is especially importantly for categorical data. 
3.1. Symptom survival analysis and application in genetics 
The study was conducted on the basis of the Department of narcology of the National medical Research center 
of Psychiatry and Neurology (SMRC PN) to them. V. M. Bekhtereva in the period 2013-2017. Within the 
double-blind placebo-controlled study, 100 patients with alcohol dependence syndrome (ICD-10) were 
randomly distributed (randomized) into 2 groups: patients of the main group (50 people) received pregabalin 
at a dosage of 150 mg / day (at night), patients of the comparison group (control group) (50 people) received 
an identical-looking placebo. The study drug was prescribed for 3 months (12 weeks), during which the 
subjects had to visit the research center on a weekly to control remission, drug compliance, as well as for 
psychometric assessments. In addition, blood samples were taken from patients. For technical reasons, 86 
patients were available for analysis, blood samples of the remaining patients were lost or DNA isolation and 
genotyping was impossible. Differences in the duration of remission in the treatment program in carriers of 
different polymorphic variants of genes and their combinations were carried out using Kaplan-Meier survival 
analysis. The significance of differences in survival curves was assessed using the Gehan’s Wilcoxon test. 
Interrelation of outcomes and separate polymorphic variants of genes were evaluated independently from the 
group of therapy. As a time scale were considered the time before retiring from the program (time before 
retiring from the program for any reason relapse, violation of the conditions of participation). 
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The dichotomous variable was considered as the dropout scale based on the following:   
    • 1 (dropped out of the treatment program),  
    • 0 (completed the treatment program).  
 The recessive model was used for the analysis - three genotypes for each polymorphic locus were 
aggregated into two groups:   
    • 0 (carriers only of major allele in homozygous state),  
    • 1 (all other genotypes).  
 Consider composition of the genetic panel selected in this study which includes code, recessive 
model and decryption.   
    • Single nucleotide polymorphisms (SNP) in the DRD2 gene of the dopamine receptor D2 gene 
rs1799732 (type 2 dopamine receptor gene) is encoded by a variable 𝐺1 where 𝐺1 = 0 when the genotype is 
𝐶𝐶 and there is a carrier only of major allele in homozygous; 𝐺1 = 1 when there are polymorphisms 𝐶𝑇, 𝑇𝑇. 
This gene is detected in significant amounts in the limbic system of the brain and plays an important role in 
the functioning of the central nervous system. It is considered an autoreceptor for dopamine (DA). 
Polymorphisms 𝐶𝑇, 𝑇𝑇 determines the reduced concentration or high severity of alcoholism. 
    • SNP in the DRD4 gene of the dopamine D4 receptor gene rs1800955 is encoded by a variable 𝐺2, 
where 𝐺2 = 0 when the genotype is 𝑇𝑇; 𝐺2 = 1 when there are polymorphisms 𝐶𝑇, 𝐶𝐶. This gene is the main 
acceptor of the neuronal impulse in the dopamine neurotransmitter system, it is located at the terminal of the 
neuron that receives the nerve impulse, and mediates the effects of dopamine as a neurotransmitter. It is 
expressed at high levels in the prefrontal cortex and is the dominant DA receptor localized in this region of the 
brain. Carriers of the minor allele 𝐶𝑇, 𝐶𝐶 are less effectively treated with serotonin and have an increased 
susceptibility to novelty seeking. 
    • SNP in the gene of the opioid 𝜇-receptots OPRM1 rs1799971 is encoded by a variable 𝐺3 where 
𝐺3 = 0 when the genotype is 𝐴𝐴; 𝐺3 = 1 when there are polymorphisms 𝐴𝐺, 𝐺𝐺. Opioid receptors of 𝜇 types 
(OPRM1) are the most important effector of the opioid reinforcing effect. The minor allele in exon 1 of the 𝜇 
opioid receptor OPRM1 gene causes the normal amino acid at residue 40, asparagine, to be replaced by 
aspartic acid. Carriers of at least one minor allele 𝐴𝐺, 𝐺𝐺 appear to have stronger cravings for alcohol than 
carriers of two major alleles. 
    • SNP in the gene of the GABA-𝛼 receptors rs567926 is encoded by a variable 𝐺4, where 𝐺4 = 0 
when the genotype is 𝑇𝑇; 𝐺4 = 1 when there are polymorphisms 𝐶𝑇, 𝐶𝐶. The gamma-amino butyric acid 
alpha receptors GABA-𝛼 is an ionotopic receptor and ligand-activated ion channel. The endogenous GABA 
ligand, upon binding of which hyperpolarization of the neuron membrane occurs, which is the basis of the 
inhibitory effect of GABA. There is evidence of the dependence of a number of polymorphisms 𝐶𝑇, 𝐶𝐶 of the 
genes of these subunits with alcohol addictive. 
    • SNP in the gene of glutamate receptor rs2832407 is encoded by a variable 𝐺5, where 𝐺5 = 0 
when the genotype is 𝐶𝐶; 𝐺5 = 1 when there are polymorphisms 𝐴𝐶, 𝐴𝐴. The study of the structure of genes 
coding for glutamate and GABA systems indicates a link between their polymorphism and the presence of 
motivation for alcohol consumption. In participants with the two major alleles genotype, treatment enhances 
self-efficacy and reduces heavy drinking. 
 
 The super-symptom method allows us to define that patients differ best in duration of remission by means the 
composite genetic factors. Groups patients with the genotypes 
[𝐺1(𝐶𝐶), 𝐺3(𝐴𝐺, 𝐴𝐴), 𝐺4(𝑇𝑇)]   𝑜𝑟   [𝐺1(𝐶𝐶), 𝐺3(𝐺𝐺), 𝐺4(𝐶𝐶, 𝐶𝑇)] were combined into one favorable group 
with the least number of relapses, which can be described by a super-symptom of the form  
 𝑆 = (1 + 𝐺1)(𝐺3 + 𝐺4)(mod2) . 
This composite factor 𝑆 means the presence one of two risk factors 𝐺3, 𝐺4 at absence of 𝐺1. Average time 
spent in the program is equal to 9.92 at 𝑆 = 1 and 6.56 at 𝑆 = 0, significance 3 of the Gehan’s Wilcoxon Test 
is equal to 𝑝 = 1.8 ⋅ 10−5. The probability of outcome is equal to 𝑝1 = 0.35(37) at 𝑆 = 1 compared to 𝑝0 =
0.82(45) in another group at 𝑆 = 0, significance of the Fisher Exact Test is equal to 𝑝 = 2.8 ⋅ 10−5. 
In combination with genes of factor 𝑆, other factors 𝑇 = 𝐺1𝐺3 + 𝐺1𝐺4 + 𝐺3𝐺4(mod2) can be 
identified. This composite factor 𝑇 means presence of at least two from three risk factors. Average time of 
 
3 Further we denote the significance 𝑝-value of statistical tests by 𝑝.  
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remission is equal to 5.68 at 𝑇 = 1 and 8.8 at 𝑇 = 0, significance of the Gehan’s Wilcoxon Test is equal to 
𝑝 = 0.0003. 
 
 
   
 
Figure  1. The Kaplan-Meier survival curves for the duration of the relapse-free period with factors: (a) 𝐺1, (b) 
combination of 𝑆 = (1 + 𝐺1)(𝐺3 + 𝐺4)(mod2) and 𝑇 = 𝐺1𝐺3 + 𝐺1𝐺4 + 𝐺3𝐺4(mod2) 
   
Thus, the outcomes from the treatment program are significantly associated with the combination of genetic 
data. Patients with two of the three genetic risk factors have a shorter recurrence-free period. If add 𝐺2 in 
selection algorithm then the most significant factor looks like  
 𝑈 = (1 + 𝐺1)(𝐺3 + 𝐺4)𝐺2(mod2). 
Average time spent in the program is equal to 10.59 at 𝑈 = 1 and 7.08 at 𝑈 = 0, significance of the Gehan’s 
Wilcoxon Test is equal to 𝑝 = 2.9 ⋅ 10−5. The probability of outcome at 𝑈 = 1 is equal to 𝑝1 = 0.22(27) 
compared to 𝑝0 = 0.78(59) in another group at 𝑈 = 0, significance of the Fisher Exact Test is equal to 𝑝 =
2 ⋅ 10−6. 
If we assume that polymorphisms of gene 𝐺2 are responsible for risk-taking, polymorphisms of gene 
𝐺1 contribute to cognitive disorders and severe alcohol dependence, polymorphisms of gene 𝐺3 indicate high 
doses of alcohol, and gene 𝐺4 helps to quickly become addicted, then we will get a description of a group of 
patients with longer remission. These patients have increased sensitivity to the search for new sensations 
(𝐺2 = 1), not prone to cognitive disorders (𝐺1 = 0), or have separately a tendency to large doses of alcohol 
(𝐺3 = 1), or a fast addiction (𝐺4 = 1). If we construct the vector (𝐺1, 𝐺2, 𝐺3, 𝐺4) then this group corresponds 
to two realizations (0,1,0,1) or (0,1,1,0) with probability of outcome 0.35. At combination (0,1,1,1) with two 
risk factors simultaneously, the probability of outcome from the treatment is a lot higher being equal to 
0.86(7). 
In the case of combination (0,1,0,0), it would seem that the situation should be better, however we have the 
probability of outcome is equal to 0.78(18). Perhaps this is due to the fact that 10 out of 18 patients have 
𝐺5 = 1, which means 𝐺5(𝐴𝑆, 𝐴𝐴)associated with heavy drinking and treatment difficulties, and the 
probability of outcome is 0.9(10). The rest 8 patients which have only one risk factor 𝐺2 = 1, while 𝐺𝑖 =
0, 𝑖 = 1,3,4,5, have nearly the same chances to complete the program or leave it since the probability of the 
outcome is 0.625(8). 
It follows from this study that outcomes from the treatment program can be predicted on the base of 
composition of the genetic panel selected in this study. 
3.2. Canonical symptom analysis and biometrical example 
Symptom analysis can be used to identify the structure of the relationship between two sets of 
categorical variables by analogy with the canonical correlation analysis. The research data set was proposed to 
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be collected from Cancer Oncology Hospital in Medicine City in Baghdad for a set of patients who were 
scheduled for biopsy, mammograms interpreted by radiologists. Laboratory and Clinical Investigations, 
Ultrasound of mammary glands and elastography provided data on mammographic results as a part of the 
standard mammographic workup. 
There are some features important for a physician to make decision whethere dangerous operation is necessary 
for treatment or not. According to the results of initial statistical processing, surgery confirms malignancy in 
85% of cases. Only a few patients with malignancy not undergoing surgery. Encoding of 11 selected 
variables is presented in Table 2. 
Table 2. Encoding signs 
  
 code   name   indicat  
A   Age 
  
 1- age less than 59 (73%)  
 0 - age greater than 59 (27%) 
D  The Oncotype DX test  
  
  
 1 - ILC nodal severe type tumore (13%)  
 0 - IDC ducts type tumor  
      in Pipe lactiferous (87%)  
G Grades of best cancer  
  
 1 - poorly differentiated tumor (67%)  
0 - moderately differentiated tumor ( 33%)  
E   Estrogen receptor positive   1 - yes(73%), 0 - no(37%) 
P   Progesterone receptor positive   1 - yes(75%), 0 - no(25%) 
H   The human epidermal  
 growth factor receptor  
 1 - HER2-positive breast cancer(73%)  
 0 - there is no antigen in tissue(27%)  
K   Proliferative activity of cells  
  
 1 - greater than 15(60%)  
 0 - ki67 less than 15 (60%)  
S   Operation removal  
 of the tumor or breast  
1 - mastectomy or Lumpectomy (56%) 
 0 - excisional biobsy (44%)  
T   Advanced type of tumor  
  
 1 - the size of the main tumor  
 more than 3 cm(68%), 0 - otherwise (32%)  
L   Lymph nodes  
  
 1 - tumor spreading  
 to the lymph node(82%) , 0 - no (18%)  
M   Metastasis  
  
 1 - distant metastasis(92%) 
 0 - No distant metastases (8%)  
  
We are interested in the dependence between left set of variables T, L, M, which indicate the severity of the 
disease, and the test results which belong to the right set.      
 
Table 3. The most significant canonical super-symptoms: R1 = P(1 + ES), L1 = ML; R2 = G(1 + A(1 + K)), 
L2 = M(1 + TL) R3 = HS(1 + D), L3 = L(1 + M), over 𝔽2. 
 
 (R1, L1) (R2, L2) (R3, L3) 
Fisher Exact Test, p 0.000003 0.027 0.003 
Sensitivity, % 51 25 100 
Accuracy, % 63 66 66 
Specificity, % 100 95 64 
 
The significant super-symptoms are presented in the Table 3. Sensitivity is the True Positive Rate (TPR), 
Specificity is the True Negative Rate (TNR), Accuracy is equal to the proportion of correctly classified 
observations. This table presents the results and analysis done for this study, the symptom analysis is used to 
identify the most significant combination of factors for predicting breast cancer severity. 
The first canonical left factor 𝐿1 = 𝑀𝐿 means the presence of distant metastases and the tumor spreading to 
the lymph nodes and the first canonical right factor 𝑅1 = 𝑃(1 + 𝐸𝑆)(mod2) means practically that 
progesterone receptor was positive and as a surgical procedure the excisional biopsy was performed. When 
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𝑅1 = 𝑃(1 + 𝐸𝑆)(mod2) = 1 then 𝐿1 = 𝑀𝐿 = 1 with probability equal to 1, but when 𝑅1 = 0 then 𝐿1 = 1 
with probability equal to 0.6. In this case we have a smaller 𝑝 = 0.000003 of Fishers Exact Test. 
The second canonical left factor 𝐿2 = 𝑀(1 + 𝑇𝐿) means presence of distant metastases and the small tumor 
non spreading to the lymph nodes, which can match the lateral breast cancer. This can be explained by the fact 
that the second canonical right factor 𝑅2 = 𝐺(1 + 𝐴(1 + 𝐾)) that highlights a small group of 9 patients with 
poorly differentiated tumor and which are of older age or have high proliferative activity of cells. In this group 
probability of the lateral breast cancer is equal to 0.78, while in the rest this probability is equal to 0.36, 𝑝 =
0.027. 
The third canonical left factor 𝐿3 = 𝐿(1 + 𝑀) means that the tumor was spreading to the lymph nodes but 
without do distant metastases. This probably corresponds to an early stage aggressive cancer. There are only 
six such patients and all of them have the third canonical right factor 𝑅3 = 𝐻𝑆(1 + 𝐷) = 1 that means surgery 
and combination of 𝐼𝐷𝐶 type with tests positive for a protein called human epidermal growth factor receptor 2 
(HER2). Among the rest, this factor 𝑅3 occurs with probability to 0.36. In addition, the third canonical pair 
has maximal Sensitivity 100% and comparable Accuracy 66% but lower Specificity. 
The study shows that the precision (accuracy) for the prediction analysis of breast cancer data is acceptable 
and can help physicians in decision making for early diagnosis. 
4. Conclusions 
In the case of multidimensional data analysis, when the individual factors are insignificant, it is possible to 
detect a risk group with a special combination of factors. That the search method described in the article is 
based on the parameterization of all possible combinations of factors by polynomials over 𝔽2. Examples of 
symptom survival analysis and canonical symptom analysis show that if is not limited to the analysis of one-
dimensional samples, interesting patterns can be obtained. 
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